Vaccine advisers to the FDA meet Thursday and Friday of this week to tackle the next round of questions about booster vaccines for Covid-19 — and they might be seeing the first trickle of data on mix-and-match boosters.
Vaccine advisers to the US Food and Drug Administration meet Thursday and Friday of this week to tackle the next round of questions about booster vaccines for Covid-19 -- and they might be seeing the first trickle of data on mix-and-match boosters.
It's been one of the biggest ongoing questions about vaccines since three different products hit the US -- is it safe, and even desirable, to mix different vaccine types?That's the last question members of the FDA's Vaccines and Related Biological Products Advisory Committee or VRBPAC will be considering. On Thursday, they'll focus on Moderna's application to add a booster dose to its two-dose vaccine schedule.
These two different delivery methods stimulate the immune system in slightly different ways, Branche said."I think the data will show that boosting is certainly likely to be very effective in conferring additional and longer protection," she said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Where America's cases, hospitalizations, deaths stand 19 months into the COVID-19 pandemicAlthough hospitalizations nationwide have been trending downward since September, more than 40,000 people remain hospitalized with COVID-19.
Lire la suite »
U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong.
Lire la suite »
Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff SayA booster shot of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, said FDA regulators, who cautioned that their data was limited
Lire la suite »
FDA Staff Don’t Take Position on Moderna Covid-19 BoosterIn an unusual move, FDA staff didn't take a position on Moderna's application for a booster shot, indicating there may be insufficient data to support one
Lire la suite »
New York’s Covid-19 Vaccine Mandate Needs Religious Exemption, Judge RulesA federal judge extended an order requiring New York state to allow religious exemptions from its Covid-19 vaccination mandate for healthcare workers, in a ruling that could help shape the legal landscape around government-required shots
Lire la suite »